Nautilus Biotechnology, Inc.
NAUT
$0.86
$0.13718.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -15.78% | -5.02% | -3.77% | 17.58% | 20.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.79% | -0.10% | 0.13% | 9.32% | 19.64% |
| Operating Income | 12.79% | 0.10% | -0.13% | -9.32% | -19.64% |
| Income Before Tax | 11.30% | -3.35% | -3.58% | -13.93% | -25.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.30% | -3.35% | -3.58% | -13.93% | -25.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.30% | -3.35% | -3.58% | -13.93% | -25.16% |
| EBIT | 12.79% | 0.10% | -0.13% | -9.32% | -19.64% |
| EBITDA | 12.86% | -0.52% | 0.12% | -9.16% | -19.33% |
| EPS Basic | 12.02% | -2.72% | -3.15% | -13.24% | -24.65% |
| Normalized Basic EPS | 11.98% | -2.95% | -3.15% | -13.24% | -24.50% |
| EPS Diluted | 12.02% | -2.72% | -3.15% | -13.24% | -24.65% |
| Normalized Diluted EPS | 11.98% | -2.95% | -3.15% | -13.24% | -24.50% |
| Average Basic Shares Outstanding | 0.81% | 0.65% | 0.42% | 0.57% | 0.44% |
| Average Diluted Shares Outstanding | 0.81% | 0.65% | 0.42% | 0.57% | 0.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |